Video: Introduction to leva

Renovia Launches “REDUCE” – a Multi-Center Randomized Controlled Trial to Study Next-Generation leva® Pelvic Digital Therapeutic System for Urinary Incontinence
Renovia Appoints Tara Butler, M.D. to its Board of Directors
Renovia Appoints Dan Levangie to its Board of Directors
Renovia Supports ACOG and WPSI Recommendations Related to Screening for Urinary Incontinence
Renovia Completes $42.3 Million Series B Financing
Renovia Announces the Appointment of Jim O’Connor as General Counsel

Corporate: (866-735-8424)
Patient Care: (855) leva-594 (855-538-2594)
Fax: 888.503.7788
info@Renoviainc.com